Prognostic and Predictive Markers of Treatment Response in Patients With PAC.
Recruiting now
Conditions studied: Pancreatic Adenocarcinoma
In brief
The objective of this study is to identify prognosis and predictive markers of response to treatments (surgery, chemotherapy,...) in patients with pancreatic adenocarcinoma. The effectiveness and tolerance of these treatments in current practice is also evaluated.
Key facts
- Study ID
- NCT05776342
- Run by
- GERCOR - Multidisciplinary Oncology Cooperative Group
- People needed
- 4050
- Starts
- 2003-01-01
- Expected to finish
- 2031-12-31
- Last updated by the study team
- 2025-03-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient with histologically confirmed pancreatic adenocarcinoma.
- Disease at a resectable, borderline, locally advanced, initially metastatic, or recurrent stage after surgery
- Diagnosis between January 1, 2003, and December 31, 2030.
- First-line treatment with chemotherapy and/or radiotherapy and/or clinical trials.
- Age ≥ 18 years.
- Written informed consent
You may not qualify if…
- Patient under guardianship, curatorship, or judicial protection.
- Pregnant or breastfeeding women.
- Any medical, psychological, or social situation that could prevent compliance with the protocol as assessed by the investigator.
- Refusal to participate in the study
Where it is running
- Hôpital Paul Brousse — Villejuif, France (enrolling)
- Hôpital Beaujon — Clichy, France (enrolling)
- CHU Lille — Lille, France (enrolling)
- HRU Nancy Site Brabois — Nancy, France (enrolling)
- Hôpital Georges Pompidou — Paris, France (enrolling)
- Hôpital Saint Antoine — Paris, France (enrolling)
- CHU Jean Minjoz — Besançon, France (enrolling)
- IHU - Institut de chirurgie guidée par l'imagerie — Strasbourg, France
- Institut Mutualiste Montsouris — Paris, France
- CHU Poitiers — Poitiers, France
- CHU - Henri Mondor — Créteil, France
- CHU Reims — Reims, France
- Centre Léon Bérard — Lyon, France
- CHU Pontchaillou — Rennes, France
- Institut Curie — Saint-Cloud, France
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.